These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1840372)

  • 1. Treatment of autoimmune patients.
    Gergely P
    Acta Biomed Ateneo Parmense; 1991; 62(3-4):125-30. PubMed ID: 1840372
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP; Cao VV; Fehér J; Gergely P
    Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus.
    Madhok R; Wu O
    Am Fam Physician; 2007 Nov; 76(9):1351-3. PubMed ID: 18019880
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical manifestations of systemic lupus erythematosus: a Cairo-Glasgow co-operative study.
    Grennan DM; Ghobarey AF; Hadidi T; El-Badawey S; Hamid HA; Dick WC; Buchanan WW
    Scott Med J; 1977 Apr; 22(2):139-45. PubMed ID: 140459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythmatosus - When to consider and management options.
    Apostolopoulos D; Hoi AY
    Aust Fam Physician; 2013 Oct; 42(10):696-700. PubMed ID: 24130970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serodiagnosis of autoimmune diseases].
    Wagner J; Andrassy K
    Dtsch Med Wochenschr; 1992 Oct; 117(41):1573-5. PubMed ID: 1396150
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study].
    Zielinski C; Müller C; Smolen J
    Acta Med Austriaca; 1988; 15(5):155-8. PubMed ID: 3064527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation in autoimmune diseases.
    Gergely P; Láng I; Gonzalez-Cabello R; Fehér J
    Tokai J Exp Clin Med; 1986; 11 Suppl():207-13. PubMed ID: 3452243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
    Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
    Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of cytostatic drugs on antinuclear antibodies in visceral lupus erythematosus].
    Mantel W; Holtz G
    Z Rheumatol; 1974; 33(7-8):241-8. PubMed ID: 4139839
    [No Abstract]   [Full Text] [Related]  

  • 12. [Optic immunofluorescence demonstration of monoclonal and polyclonal antinuclear antibodies (ANA) in rheumatoid arthritis (RA) and lupus erythematosus disseminatus (LED)].
    Dreher R; Helmke K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():808-13. PubMed ID: 417508
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of cryoglobulins in the clinical course of systemic lupus erythematosus].
    Ortega González G; Molina Boix M; Bermudo Ruiz J; Pedro de Lelis F; Paricio Núñez P; Madrid Conesa A
    Med Clin (Barc); 1984 Sep; 83(9):358-60. PubMed ID: 6334206
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological studies in systemic lupus erythematosus.
    Jin OC; Jacob E; Chua D; Lan YS; Hsii FP
    J Med Assoc Thai; 1978 Jan; 61 Suppl 1():10-7. PubMed ID: 304878
    [No Abstract]   [Full Text] [Related]  

  • 15. Two days of internal medicine "systemic lupus erythematosus".
    Lipsmeyer EA
    J Ark Med Soc; 1980 Sep; 77(4):165-7. PubMed ID: 6447684
    [No Abstract]   [Full Text] [Related]  

  • 16. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
    Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
    Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.
    Clarke MC; Carr R; Burdash NM; Chen ZY; Ainsworth SK
    Diagn Immunol; 1986; 4(6):288-93. PubMed ID: 3545632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus.
    Ludivico CL; Zweiman B; Myers AR; Hebert J; Green PA
    J Rheumatol; 1980; 7(6):843-9. PubMed ID: 6970815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic findings, thrombocytopenia and disease activity in lupus nephritis.
    Clark WF; Linton AL; Cordy PE; Keown PE; Lohmann RC; Lindsay RM
    Can Med Assoc J; 1978 Jun; 118(11):1391-5. PubMed ID: 350367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New approaches to the therapy of diffuse inflammatory diseases of the connective tissue].
    González T; Rodríguez-Lozano B; Hernández-Beriaín JA
    Med Clin (Barc); 1991 Oct; 97(11):424-30. PubMed ID: 1961050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.